Center for Reproductive Medicine & Robotic Surgery LLCMarch 11, 2024

FDA 483 - Center for Reproductive Medicine & Robotic Surgery LLC - March 11, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Center for Reproductive Medicine & Robotic Surgery LLC

Record Details

The Center for Reproductive Medicine & Robotic Surgery LLC in Saint Louis, MO, received a Form 483 for two significant observations during an FDA inspection. The firm failed to adequately screen oocyte donors for numerous communicable disease risk factors, including Zika virus, using an insufficient medical history questionnaire. Additionally, the facility lacked a standard operating procedure for the release of HCT/Ps from donors who test reactive for cytomegalovirus.

Company: Center for Reproductive Medicine & Robotic Surgery LLC
Inspection Date: March 11, 2024
Product Type: Biologics
Office: Division of Human and Animal Food Operations - West II
Person: Esther A. Ofori

Open in Dashboard

ID · 18569d17-62d2-4bbb-b299-57cbcca9b4e3